Vicore sells rights to IPF drug in Japan; Roche to lay off 340 workers; Sensorion’s €50M offering

Plus, news about Tenaya Therapeutics, Adverum Biotechnologies, YS Biopharma, Evoke Pharma and BioXcel Therapeutics:

Nippon Shinyaku gets rights in Japan to IPF drug: The Japanese pharma company is paying Vicore Pharma $10 million upfront in a deal worth up to $275 million for Japan rights to…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks